top of page

Montai Health's CEO talks about using AI to develop small molecules at #HLTH2023

  • blonca9
  • Oct 9, 2023
  • 1 min read

Updated: Oct 19, 2023

Margo Georgiadis describes how Montai is trying to harness anthromolecule chemistry to tackle disease, lesson's learned from the AI ambition of companies that have come before, and how tailoring molecules in a hyperspecific way might avoid one of the big pitfalls of the Inflation Reduction Act.



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter

@BiotechTVHQ

  • LinkedIn

BiotechTV

  • Facebook

BiotechTVHQ

  • TikTok

@BiotechTV

  • Instagram

@BiotechTVHQ

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Allucent logo_tagline.png

Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.

Learn more about Allucent

bottom of page